Pacira Non Recurring from 2010 to 2026
| PCRX Stock | USD 21.60 1.33 5.80% |
Non Recurring | First Reported 2008-12-31 | Previous Quarter 0.0 | Current Value 0.0 | Quarterly Volatility 0.0 |
Check Pacira BioSciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pacira BioSciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 95.1 M, Interest Expense of 15.3 M or Selling General Administrative of 147.4 M, as well as many indicators such as Price To Sales Ratio of 1.36, Dividend Yield of 0.0 or PTB Ratio of 1.22. Pacira financial statements analysis is a perfect complement when working with Pacira BioSciences Valuation or Volatility modules.
Pacira | Non Recurring | Build AI portfolio with Pacira Stock |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Pacira Stock Analysis
When running Pacira BioSciences' price analysis, check to measure Pacira BioSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira BioSciences is operating at the current time. Most of Pacira BioSciences' value examination focuses on studying past and present price action to predict the probability of Pacira BioSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira BioSciences' price. Additionally, you may evaluate how the addition of Pacira BioSciences to your portfolios can decrease your overall portfolio volatility.